1 | neonatal nhf therapy overview | | | | | | | 3 | 0.36% |
2 | a review of studies | | | | | | | 3 | 0.36% |
3 | used fp optiflow™ systems | | | | | | | 3 | 0.36% |
4 | majority used fp optiflow™ | | | | | | | 3 | 0.36% |
5 | the majority used fp | | | | | | | 3 | 0.36% |
6 | the body of nhf | | | | | | | 3 | 0.36% |
7 | comprising the body of | | | | | | | 3 | 0.36% |
8 | studies comprising the body | | | | | | | 3 | 0.36% |
9 | of studies comprising the | | | | | | | 3 | 0.36% |
10 | optiflow™ systems read about | | | | | | | 3 | 0.36% |
11 | review of studies comprising | | | | | | | 3 | 0.36% |
12 | optiflow thrive in anesthesia | | | | | | | 3 | 0.36% |
13 | fp optiflow™ systems read | | | | | | | 3 | 0.36% |
14 | neonatal cpap therapy overview | | | | | | | 2 | 0.24% |
15 | overview noninvasive respiratory support | | | | | | | 2 | 0.24% |
16 | noninvasive respiratory support that | | | | | | | 2 | 0.24% |
17 | respiratory support that provides | | | | | | | 2 | 0.24% |
18 | support that provides a | | | | | | | 2 | 0.24% |
19 | that provides a continuous | | | | | | | 2 | 0.24% |
20 | breathing neonatal cpap therapy | | | | | | | 2 | 0.24% |
21 | spontaneous breathing neonatal cpap | | | | | | | 2 | 0.24% |
22 | australia brazil canada canada | | | | | | | 2 | 0.24% |
23 | ventilation therapy overview respiratory | | | | | | | 2 | 0.24% |
24 | neonatal invasive ventilation therapy | | | | | | | 2 | 0.24% |
25 | global privacy statement recruitment | | | | | | | 2 | 0.24% |
26 | limited global privacy statement | | | | | | | 2 | 0.24% |
27 | healthcare limited global privacy | | | | | | | 2 | 0.24% |
28 | surgery optiflow thrive in | | | | | | | 2 | 0.24% |
29 | assist ventilation of the | | | | | | | 2 | 0.24% |
30 | masks with vented and | | | | | | | 2 | 0.24% |
31 | providing optimal humidity for | | | | | | | 2 | 0.24% |
32 | noninvasive ventilation featuring under | | | | | | | 2 | 0.24% |
33 | ventilation featuring under nose | | | | | | | 2 | 0.24% |
34 | featuring under nose niv | | | | | | | 2 | 0.24% |
35 | masks and full face | | | | | | | 2 | 0.24% |
36 | niv masks with vented | | | | | | | 2 | 0.24% |
37 | between comfort and effective | | | | | | | 2 | 0.24% |
38 | nhf therapy overview noninvasive | | | | | | | 2 | 0.24% |
39 | vented and nonvented options | | | | | | | 2 | 0.24% |
40 | and nonvented options to | | | | | | | 2 | 0.24% |